Evidence map›Paper›PMID 42294027›Full record

ReviewACS polymers Au2026

Upcycling of Commercial Biobased Polyester BioplasticsTurning Used or Spoiled Materials into Added-Value Products.

Vojtěch Jašek, Silvestr Figalla, Radek Přikryl

Abstract readReview
In one paragraph

Review in ACS polymers Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vojtěch JašekInstitute of Materials Chemistry, Faculty of Chemistry, Brno University of Technology, 61200 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-8020-4948
Silvestr FigallaInstitute of Materials Chemistry, Faculty of Chemistry, Brno University of Technology, 61200 Brno, Czech Republic.
Radek PřikrylInstitute of Materials Chemistry, Faculty of Chemistry, Brno University of Technology, 61200 Brno, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioplastics incorporate different renewable sources via direct biosynthesis or biotechnological intermediates, contributing to the eventual production of a biobased system. Sustainable polymers and materials represent an essential substitute for petrochemical intermediates and the synthesis of applied compounds. We listed, described, and discussed three main groups of commercially applied and produced bioplastics: polyhydroxyalkanoates (PHAs), polylactic acid/polylactide (PLA), and polybutylene succinate (PBS). Although all the mentioned biobased polymers possess biodegradability at specific conditions, their waste or spoiled primary products have significant potential for new and diverse applications. The thermally degraded, hydrolyzed, or physically aged biopolyesters lack sufficient performance in their initial applications; upcycling is an alternative and promising strategy that produces valorized, added-value products or complex multistep-derived functional systems. This comprehensive review describes the major challenges that the discussed biobased polymers face, identifies fundamental chemical approaches for bioplastics as entering substances, and outlines the potential and outlook for the waste-based molecules and precursors produced. The eventual alternative applications include the pharmaceutical industry, the cosmetics segment, the production of chemical intermediates and reactants for organic synthesis, and various functional and circular materials, such as recyclable thermoplastics and thermoset vitrimers.

Indexed as

biobased materialsbioplasticsdepolymerizationPBSPHAPLApolyestersupcyclingvalorizing

Identifiers

PMID42294027
PMCPMC13261733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.